Violation Tracker Industry Summary Page

Industry: 
pharmaceuticals
Penalty Total since 2000: 
$71,670,170,863
Number of Records: 
968
Note: 
The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.

Top 10 Parent CompaniesTotal Penalty $Number of Records
Purdue Pharma$19,124,272,78711
Johnson & Johnson$9,248,447,76359
GlaxoSmithKline$7,837,200,25835
Merck$5,548,085,58178
Pfizer$4,660,896,33371
AbbVie$3,203,142,50749
Teva Pharmaceutical Industries$2,735,215,32853
Novartis$2,526,283,57039
Mallinckrodt$1,755,367,47820
Bristol-Myers Squibb$1,704,939,82039


Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
Company Parent Primary Offense Type Year Agency Penalty Amountsort icon
Mylan Laboratories et al. Viatris price-fixing or anti-competitive practices 2000 MULTI-AG (*) $108,000,000
GlaxoSmithKline, LLC GlaxoSmithKline kickbacks and bribery 2014 MULTI-AG $105,000,000
Novartis Pharmaceuticals Corp. Novartis kickbacks and bribery 2020 MULTI-AG $103,000,000
Mylan Laboratories, Inc. Viatris consumer protection violation 2000 FTC $100,000,000
Mallinckrodt ARD Inc Mallinckrodt price-fixing or anti-competitive practices 2017 FTC $100,000,000
Astellas Pharma US Inc. Astellas Pharma False Claims Act and related 2019 DOJ_CIVIL $100,000,000
Bristol-Myers Squibb Co. Bristol-Myers Squibb price-fixing or anti-competitive practices 2003 MULTI-AG $100,000,000
Mallinckrodt plc Mallinckrodt price-fixing or anti-competitive practices 2017 MULTI-AG (*) $100,000,000
Novartis Novartis wage and hour violation 2012 private lawsuit-federal $99,000,000
Gilead Sciences, Inc. Gilead Sciences False Claims Act and related 2020 DOJ_CIVIL $97,000,000
Aventis Pharmaceutical Inc. Sanofi False Claims Act and related 2009 DOJ_CIVIL $95,500,000
Boehringer Ingelheim Pharmaceuticals Inc. Boehringer Ingelheim off-label or unapproved promotion of medical products 2012 FDA $95,000,000
Boehringer-Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $95,000,000
Schering-Plough Corporation Merck off-label or unapproved promotion of medical products 2006 MULTI-AG (*) $91,602,000
GlaxoSmithKline LLC GlaxoSmithKline drug or medical equipment safety violation 2012 MULTI-AG $90,000,000
Novartis Pharmaceuticals Corporation Novartis off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $88,258,694
Scios Inc. Johnson & Johnson off-label or unapproved promotion of medical products 2011 FDA $85,000,000
Teva Pharmaceuticals Teva Pharmaceutical Industries Controlled Substances Act violation 2019 OK-AG $85,000,000
Depuy Orthopaedics Inc. Johnson & Johnson False Claims Act and related 2007 USAO $84,700,000
Novartis Pharmaceuticals Corporation Novartis kickbacks and bribery 2015 MULTI-AG (*) $83,129,754
Ortho-McNeil Pharmaceutical LLC Johnson & Johnson off-label or unapproved promotion of medical products 2010 FDA $81,000,000
Bristol-Myers Squibb Bristol-Myers Squibb False Claims Act and related 2021 USAO $75,000,000
Bristol Myers Squibb Co. Bristol-Myers Squibb False Claims Act and related 2021 MULTI-AG $75,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation Novartis off-label or unapproved promotion of medical products 2010 FDA $72,500,000
Amgen Inc. Amgen off-label or unapproved promotion of medical products 2015 MULTI-AG $71,000,000
GlaxoSmithKline GlaxoSmithKline False Claims Act and related 2006 MULTI-AG $70,000,000
Watson Pharmaceuticals AbbVie False Claims Act and related 2011 MULTI-AG $70,000,000
Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries consumer protection violation 2019 CA-AG $69,000,000
AstraZeneca Pharmaceuticals AstraZeneca off-label or unapproved promotion of medical products 2011 MULTI-AG $68,500,000
OSI Pharmaceuticals LLC Astellas Pharma False Claims Act and related 2016 DOJ_CIVIL $67,000,000
Eli Lilly and Company Eli Lilly off-label or unapproved promotion of medical products 2008 MULTI-AG $62,000,000
LifeScan Inc. Johnson & Johnson drug or medical equipment safety violation 2000 USAO $60,000,000
Forest Pharmaceuticals Inc. AbbVie False Claims Act and related 2010 MULTI-AG (*) $60,000,000
Johnson & Johnson Vision Care, Inc. Johnson & Johnson price-fixing or anti-competitive practices 2001 MULTI-AG $60,000,000
Pfizer Inc. Pfizer off-label or unapproved promotion of medical products 2008 MULTI-AG $60,000,000
Novo Nordisk Inc. Novo Holdings A/S False Claims Act and related 2017 DOJ_CIVIL $58,650,000
Merck & Co. Merck consumer protection violation 2008 MULTI-AG $58,000,000
Jazz Pharmaceuticals plc Jazz Pharmaceuticals False Claims Act and related 2019 DOJ_CIVIL $57,000,000
Shire Pharmaceuticals LLC Takeda Pharmaceutical off-label or unapproved promotion of medical products 2014 FDA $56,500,000
Pfizer Inc. Pfizer drug or medical equipment safety violation 2012 FDA $55,000,000
Bristol-Myers Squibb Bristol-Myers Squibb price-fixing or anti-competitive practices 2003 MULTI-AG $55,000,000
GlaxoSmithKline LLC GlaxoSmithKline False Claims Act and related 2019 IL-AG $54,653,931
Salix Pharmaceuticals Inc. Bausch Health kickbacks and bribery 2016 USAO $54,000,000
Lundbeck LLC Lundbeck False Claims Act and related 2019 DOJ_CIVIL $52,600,000
Endo Health Solutions Endo International off-label or unapproved promotion of medical products 2021 NY-AG $50,000,000
Johnson & Johnson Johnson & Johnson False Claims Act and related 2019 IL-AG $49,505,368
Merck & Co., Inc. Merck benefit plan administrator violation 2011 private lawsuit-federal $49,500,000
Pfizer Corporation Pfizer False Claims Act and related 2002 DOJ_CIVIL $49,000,000
Johnson & Johnson Johnson & Johnson Foreign Corrupt Practices Act 2011 SEC $48,600,000
Hoffman-LaRoche Roche price-fixing or anti-competitive practices 2000 CA-AG $47,498,000
SmithKline Beecham GlaxoSmithKline False Claims Act and related 2003 DOJ_CIVIL $47,000,000
AstraZeneca LP AstraZeneca False Claims Act and related 2015 DOJ_CIVIL $46,500,000
AstraZeneca LP AstraZeneca False Claims Act and related 2015 MULTI-AG (*) $46,500,000
Par Pharmaceutical Companies Inc. Endo International off-label or unapproved promotion of medical products 2013 FDA $45,000,000
Bausch Health Bausch Health accounting fraud or deficiencies 2020 SEC $45,000,000
Serono Laboratories Inc. Merck KGaA (EMD) False Claims Act and related 2011 DOJ_CIVIL $44,300,000
EMD Serono, Inc. Merck KGaA (EMD) False Claims Act and related 2011 MULTI-AG (*) $44,300,000
Elan Corp. Perrigo off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $43,399,040
Pfizer Inc. Pfizer off-label or unapproved promotion of medical products 2012 MULTI-AG $42,900,000
Alpharma Inc. Pfizer False Claims Act and related 2010 DOJ_CIVIL $42,500,000
Kos Pharmaceuticals AbbVie kickbacks and bribery 2010 FDA $41,500,000
Briston-Myers Squibb Bristol-Myers Squibb benefit plan administrator violation 2005 private lawsuit-federal $41,220,000
Pfizer Inc. Pfizer False Claims Act and related 2019 IL-AG $41,047,101
GlaxoSmithKline, LLC GlaxoSmithKline drug or medical equipment safety violation 2011 MULTI-AG $40,750,000
Andrx Corporation AbbVie price-fixing or anti-competitive practices 2003 MULTI-AG $40,000,000
Aventis Pharmaceutical Inc. Sanofi False Claims Act and related 2009 MULTI-AG (*) $40,000,000
Aventis Pharmaceuticals Inc. Sanofi price-fixing or anti-competitive practices 2003 MULTI-AG $40,000,000
GlaxoSmithKline GlaxoSmithKline False Claims Act and related 2003 MULTI-AG $40,000,000
Daiichi Sankyo Inc. Daiichi Sankyo False Claims Act and related 2015 DOJ_CIVIL $39,000,000
Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals Endo International drug or medical equipment safety violation 2015 USAO $39,000,000
Daiichi Sankyo, Inc. Daiichi Sankyo False Claims Act and related 2015 MULTI-AG $39,000,000
Endo Health Solutions Endo International False Claims Act and related 2015 MULTI-AG (*) $39,000,000
Alere Inc. Abbott Laboratories False Claims Act and related 2021 DOJ_CIVIL $38,750,000
Forest Laboratories and Forest Pharmaceuticals AbbVie False Claims Act and related 2016 DOJ_CIVIL $38,000,000
InterMune Inc. Roche off-label or unapproved promotion of medical products 2006 FDA $36,900,000
Eli Lilly and Company Eli Lilly off-label or unapproved promotion of medical products 2005 FDA $36,000,000
Organon USA Inc Organon & Co. price-fixing or anti-competitive practices 2004 MULTI-AG $36,000,000
Mallinckrodt LLC Mallinckrodt Controlled Substances Act violation 2017 DEA $35,000,000
Aegerion Pharmaceuticals Inc. Amryt Pharma drug or medical equipment safety violation 2017 DOJ_CIVIL $35,000,000
Pfizer Pfizer off-label or unapproved promotion of medical products 2014 MULTI-AG $35,000,000
UCB Inc. UCB off-label or unapproved promotion of medical products 2011 FDA $34,000,000
Genentech Inc. Roche False Claims Act and related 2016 DOJ_CIVIL $33,500,000
ISTA Pharmaceuticals, Inc. Bausch Health False Claims Act and related 2013 DOJ_CIVIL $33,500,000
OSI Pharmaceuticals LLC Astellas Pharma False Claims Act and related 2016 DOJ_CIVIL $33,500,000
Watson, Inc. AbbVie False Claims Act and related 2018 MS-AG $33,408,547
Alere Inc. Abbott Laboratories False Claims Act and related 2018 DOJ_CIVIL $33,200,000
Johnson & Johnson Johnson & Johnson drug or medical equipment safety violation 2017 MULTI-AG $33,000,000
Genzyme Corporation Sanofi drug or medical equipment safety violation 2015 FDA $32,587,439
Abbott Laboratories Abbott Laboratories False Claims Act and related 2003 MULTI-AG (*) $32,500,000
Organon Organon & Co. off-label or unapproved promotion of medical products 2014 MULTI-AG $31,000,000
Schering-Plough Merck False Claims Act and related 2008 MO-AG $31,000,000
LifeScan, Inc. Johnson & Johnson drug or medical equipment safety violation 2003 MULTI-AG $30,600,000
Sandoz, Inc. Novartis False Claims Act and related 2011 MS-AG $30,110,618
Mylan N.V. Viatris investor protection violation 2019 SEC $30,000,000
Wyeth-Ayerst Laboratories Division Pfizer drug or medical equipment safety violation 2000 FDA $30,000,000
Bristol-Myers Squibb Bristol-Myers Squibb kickbacks and bribery 2016 CA-INS $30,000,000
Pharmacia Corporation Viatris False Claims Act and related 2013 WI-AG $29,453,247
Eli Lilly and Company Eli Lilly Foreign Corrupt Practices Act 2012 SEC $29,398,734
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC Teva Pharmaceutical Industries False Claims Act and related 2011 TX-AG $29,230,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation Novartis off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $29,000,000
Abbott Laboratories Inc. AbbVie False Claims Act and related 2008 TX-AG $28,000,000
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)